Moderna (MRNA) News Today → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free MRNA Stock Alerts $132.68 +3.62 (+2.80%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 2:37 PM | finance.yahoo.comBiotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMYMay 16 at 7:56 AM | marketbeat.comJump Financial LLC Buys 11,080 Shares of Moderna, Inc. (NASDAQ:MRNA)Jump Financial LLC increased its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 402.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,835 shares of the company's stock after buying an additional 11,08May 16 at 6:38 AM | americanbankingnews.comModerna (NASDAQ:MRNA) Upgraded by Evercore ISI to HoldMay 16 at 3:32 AM | americanbankingnews.comModerna (NASDAQ:MRNA) Coverage Initiated by Analysts at Evercore ISIMay 15 at 4:25 PM | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Acquires 23,288 Shares of Moderna, Inc. (NASDAQ:MRNA)Mitsubishi UFJ Asset Management Co. Ltd. raised its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 6.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 386,741 shares of the company's stock after purchasing aMay 15 at 12:19 PM | seekingalpha.comModerna Q1: A Promising Pipeline Is UndervaluedMay 15 at 3:33 AM | msn.comModerna Japan aiming for combined COVID-flu mRNA vaccine clinical trials this winterMay 14 at 5:32 PM | msn.comEvercore ISI Group Initiates Coverage of Moderna (MRNA) with In-Line RecommendationMay 14 at 12:31 PM | finance.yahoo.comModerna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?May 14 at 8:10 AM | marketbeat.comModerna (NASDAQ:MRNA) Now Covered by Evercore ISIEvercore ISI assumed coverage on shares of Moderna in a research report on Tuesday. They set an "in-line" rating and a $120.00 target price on the stock.May 14 at 6:53 AM | marketbeat.comTeacher Retirement System of Texas Sells 10,124 Shares of Moderna, Inc. (NASDAQ:MRNA)Teacher Retirement System of Texas lowered its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 11.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 75,700 shares of the company's stockMay 14 at 6:35 AM | fool.comIs This a Setback for Moderna?May 14 at 5:40 AM | americanbankingnews.comModerna, Inc. (NASDAQ:MRNA) President Stephen Hoge Sells 255 Shares of StockMay 14 at 5:39 AM | insidertrades.comInsider Selling: Moderna, Inc. (NASDAQ:MRNA) President Sells 255 Shares of StockMay 13, 2024 | marketbeat.comModerna (NASDAQ:MRNA) Shares Up 8%Moderna (NASDAQ:MRNA) Stock Price Up 8%May 13, 2024 | marketbeat.comStephen Hoge Sells 255 Shares of Moderna, Inc. (NASDAQ:MRNA) StockModerna, Inc. (NASDAQ:MRNA - Get Free Report) President Stephen Hoge sold 255 shares of the stock in a transaction on Friday, May 10th. The stock was sold at an average price of $120.96, for a total value of $30,844.80. Following the completion of the sale, the president now directly owns 1,486,508 shares in the company, valued at $179,808,007.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.May 13, 2024 | finance.yahoo.comCompany News For May 13, 2024May 13, 2024 | finance.yahoo.comWhile shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week ago aren't so fortunateMay 13, 2024 | fool.comBull Market and Beyond: 2 Stocks Just Waiting to SoarMay 13, 2024 | msn.comExperts Dismiss Fears Over mRNA Vaccines Following AstraZeneca ExitMay 12, 2024 | marketbeat.comDana Investment Advisors Inc. Has $1.13 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)Dana Investment Advisors Inc. raised its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 193.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,312 shares of the company's stock afMay 12, 2024 | fool.comModerna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?May 12, 2024 | insidertrades.comNoubar Afeyan Sells 15,000 Shares of Moderna, Inc. (NASDAQ:MRNA) StockMay 11, 2024 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Sold by Mawer Investment Management Ltd.Mawer Investment Management Ltd. cut its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 1.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,795,949 shares of the company's stock aMay 11, 2024 | bizjournals.comFDA delays decision date for Moderna's RSV vaccineMay 11, 2024 | markets.businessinsider.comModerna: FDA Delays BLA Review Of RSV Vaccine MRNA-1345May 11, 2024 | msn.comModerna says FDA will not complete review of RSV vaccine by May 12 deadlineMay 10, 2024 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Stake Boosted by Intrinsic Value Partners LLCIntrinsic Value Partners LLC lifted its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 32.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,371 shares of the company's stock after buying anMay 10, 2024 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Director Sells $1,825,200.00 in StockModerna, Inc. (NASDAQ:MRNA - Get Free Report) Director Noubar Afeyan sold 15,000 shares of the firm's stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $121.68, for a total transaction of $1,825,200.00. Following the completion of the sale, the director now owns 2,011,931 shares of the company's stock, valued at $244,811,764.08. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.May 10, 2024 | investopedia.comModerna Stock Slips as FDA Delays RSV Vaccine ApprovalMay 10, 2024 | marketbeat.comWill the Biotech Sector Shift From Lagger to Leader?The biotech sector and its popular ETF, the iShares Biotechnology ETF NASDAQ: IBB, have lagged the overall market during the year, with its shares slightly red. However, in recent weeks, the sector has enjoyed a significant rally after bouncing off its uptrend support and now consolidating near several major Simple Moving Averages (SMA).May 10, 2024 | marketbeat.comWill the Biotech Sector Shift From Lagger to Leader?The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs.May 10, 2024 | reuters.comUS FDA pushes decision on Moderna's RSV vaccine to end of this monthMay 10, 2024 | cnbc.comModerna says FDA delayed RSV vaccine approval to end of MayMay 9, 2024 | msn.comModerna’s First Vaccine Was a Big Hit. Its Second Is a Let DownMay 9, 2024 | finance.yahoo.comPositive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past yearMay 9, 2024 | msn.comModerna's New RSV Vaccine Undercuts the Promise of mRNAMay 9, 2024 | marketbeat.comNational Pension Service Acquires 19,961 Shares of Moderna, Inc. (NASDAQ:MRNA)National Pension Service raised its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 2.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 712,056 shares of the company's stock after buying anMay 9, 2024 | fool.comIf You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have TodayMay 9, 2024 | americanbankingnews.comModerna (NASDAQ:MRNA) PT Raised to $151.00 at UBS GroupMay 8, 2024 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Acquired by Victory Capital Management Inc.Victory Capital Management Inc. increased its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 7.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 303,132 shares of the company's stock after purchasing anMay 7, 2024 | marketbeat.comUBS Group Boosts Moderna (NASDAQ:MRNA) Price Target to $151.00UBS Group increased their price objective on shares of Moderna from $143.00 to $151.00 and gave the stock a "buy" rating in a research report on Tuesday.May 7, 2024 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Sold by National Bank of Canada FINational Bank of Canada FI lowered its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 56.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 310,380 shares of the company's stock after selling 398,681 shares during the quarter. National Bank ofMay 7, 2024 | msn.comHow mRNA vaccines could be personalized cancer curesMay 7, 2024 | americanbankingnews.comModerna (NASDAQ:MRNA) Price Target Raised to $163.00 at OppenheimerMay 7, 2024 | americanbankingnews.comModerna (NASDAQ:MRNA) PT Raised to $106.00May 7, 2024 | americanbankingnews.comModerna (NASDAQ:MRNA) Shares Down 3.4% Following Insider SellingMay 6, 2024 | marketbeat.comModerna (NASDAQ:MRNA) Shares Down 3.4% After Insider SellingModerna (NASDAQ:MRNA) Trading Down 3.4% Following Insider SellingMay 6, 2024 | markets.businessinsider.comMaintaining Hold on Moderna: Balancing Strong Q1 Sales with Future Uncertainties and Pipeline ProgressMay 6, 2024 | marketbeat.comPfizer Finds a Foothold After a Solid Q1 2024 Earnings Report (MRNA)After a painful two-year selloff, Pfizer shareholders may have finally gained a foothold after the company delivered a solid Q1 2024 earnings report Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… MRNA Media Mentions By Week MRNA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.530.54▲Average Medical News Sentiment MRNA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼3918▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Seagen News Biogen News argenx News BioNTech News Neurocrine Biosciences News Bio-Techne News Gilead Sciences News Qiagen News Repligen News CRISPR Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
